Report Feature
The future of the global HER2 antibody market looks promising with opportunities in hospitals and medical centers. The global HER2 antibody market is expected to grow with a CAGR of 8%-10% from 2020 to 2025. The major drivers for this market are increasing prevalence of HER2 positive, rising awareness of personalized medicines, and increasing geriatric population.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global HER2 antibody market report, please download the report brochure.
In this market, transtuzumab is the largest type of treatment drug of HER2 antibody. Growth in various segments of the HER2 antibody market are given below:
The study includes trends and forecast for the global HER2 antibody market by type of treatment drug, application, sales channel, and region as follows:
By Type of Treatment Drugs [Value ($ Million) shipment analysis for 2014 – 2025]:
- Trastuzumab
- Lapatinib
- Ado-trastuzumab Emtansine
- Pertuzumab
- Everolimus
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Hospitals
- Medical Centers
By Distribution Channel [Value ($ Million) shipment analysis for 2014 – 2025]:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the HER2 antibody companies profiled in this report include Roche, Novartis, Abnova, Pfizer, InvivoGen, Biocon, Bio-Techne, Samsung Bioepis and Celltrion.
Lucintel forecasts that trastuzumab will remain the largest treatment drug type segment over the forecast period due to increasing prevalence of cancer.
North America will remain the largest region over the forecast period due to developed healthcare infrastructure and increasing awareness of population regarding the treatment of HER2 breast cancer in the region.
|
Features of the Global HER2 Antibody Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global HER2 antibody market by type of treatment drugs (trastuzumab, lapatinib, ado-trastuzumab emtansine, pertuzumab, and everolimus), application (hospitals and medical centers), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, and others) and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global HER2 antibody market? Q.5 What are the business risks and threats to the global HER2 antibody market? Q.6 What are the emerging trends in this HER2 antibody market and the reasons behind them? Q.7 What are some changing demands of customers in this HER2 antibody market? Q.8 What are the new developments in this HER2 antibody market? Which companies are leading these developments? Q.9 Who are the major players in this HER2 antibody market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this HER2 antibody market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global HER2 antibody market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Type of Treatment Drugs (Trastuzumab, Lapatinib, Ado-trastuzumab Emtansine, Pertuzumab, and Everolimus), Application (Hospitals and Medical Centers), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global HER2 Antibody Market
4.1 Global HER2 Antibody Market by Region
4.2.1 Market by Type of Treatment Drugs: Trastuzumab, Lapatinib, Ado-trastuzumab Emtansine, Pertuzumab, and Everolimus
4.2.2 Market by Hospitals and Medical Centers
4.2.3 Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
4.2.4 The United States HER2 Antibody Market
4.2.5 The Canadian HER2 Antibody Market
4.2.6 The Mexican HER2 Antibody Market
4.3.1 Market by Type of Treatment Drugs: Trastuzumab, Lapatinib, Ado-trastuzumab Emtansine, Pertuzumab, and Everolimus
4.3.2 Market by Hospitals and Medical Centers
4.3.3 Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
4.3.4 The HER2 Antibody Market of United Kingdom
4.3.5 The German HER2 Antibody Market
4.3.6 The French HER2 Antibody Market
4.4.1 Market by Type of Treatment Drugs: Trastuzumab, Lapatinib, Ado-trastuzumab Emtansine, Pertuzumab, and Everolimus
4.4.2 Market by Hospitals and Medical Centers
4.4.3 Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
4.4.4 The Chinese HER2 Antibody Market
4.4.5 The Indian HER2 Antibody Market
4.4.6 The Japanese HER2 Antibody Market
4.5.1 Market by Type of Treatment Drugs: Trastuzumab, Lapatinib, Ado-trastuzumab Emtansine, Pertuzumab, and Everolimus
4.5.2 Market by Hospitals and Medical Centers
4.5.3 Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
4.5.4 Brazilian HER2 Antibody Market
7.1.1 Growth Opportunities for the Global HER2 Antibody Market by Type of Treatment Drugs
7.1.2 Growth Opportunities for the Global HER2 Antibody Market by Application
7.1.3 Growth Opportunities for the Global HER2 Antibody Market by Distribution Channel
7.1.4 Growth Opportunities for the Global HER2 Antibody Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
